
(AGENPARL) – NEW HAVEN, CONNECTICUT (USA) gio 06 aprile 2023 An upcoming participant-centric trial, led by Yale’s Dr. Harlan Krumholz and Akiko Iwasaki, will test of effects of the antiviral drug Paxlovid on long COVID.
Fonte/Source: https://medicine.yale.edu/news-article/participant-centric-trial-will-test-if-anti-viral-paxlovid-can-help-with-long-covid/